UM

Browse/Search Results:  1-10 of 15 Help

Selected(0)Clear Items/Page:    Sort:
Ginsenoside Rk1 Ameliorates ER Stress-Induced Apoptosis through Directly Activating IGF-1R in Mouse Pancreatic β -Cells and Diabetic Pancreas Journal article
Vong, Chi Teng, Tan, Dechao, Liao, Fengyun, Chen, Zhejie, Chen, Zhangmei, Tseng, Hisa Hui Ling, Cheang, Wai San, Wang, Shengpeng, Wang, Yitao. Ginsenoside Rk1 Ameliorates ER Stress-Induced Apoptosis through Directly Activating IGF-1R in Mouse Pancreatic β -Cells and Diabetic Pancreas[J]. American Journal of Chinese Medicine, 2024, 52(4), 1195-1211.
Authors:  Vong, Chi Teng;  Tan, Dechao;  Liao, Fengyun;  Chen, Zhejie;  Chen, Zhangmei; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:4.8/5.0 | Submit date:2024/07/04
Diabetes  Diabetic Pancreas  Er Stress  Ginsenoside Rk1  Insulin-like Growth Factor 1 Receptor  β -cell Apoptosis  
Ganoderma lucidum: a comprehensive review of phytochemistry, efficacy, safety and clinical study Journal article
Wu, Sijia, Zhang, Siyuan, Peng, Bo, Tan, Dechao, Wu, Mingyue, Wei, Jin Chao, Wang, Yi Tao, Luo, Hua. Ganoderma lucidum: a comprehensive review of phytochemistry, efficacy, safety and clinical study[J]. Food Science and Human Wellness, 2024, 13(2), 568-596.
Authors:  Wu, Sijia;  Zhang, Siyuan;  Peng, Bo;  Tan, Dechao;  Wu, Mingyue; et al.
Favorite | TC[WOS]:0 TC[Scopus]:29  IF:5.6/6.8 | Submit date:2024/04/02
Clinical Study  Efficacy  Ganoderma Lucidum  Phytochemistry  Safety  
Ginsenoside Rk1 improves endothelial function in diabetes through activating peroxisome proliferator-activated receptors Journal article
Miao, Lingchao, Zhou, Yan, Tan, Dechao, Zhou, Chunxiu, Ruan, Cheng Chao, Wang, Shengpeng, Wang, Yitao, Vong, Chi Teng, Cheang, Wai San. Ginsenoside Rk1 improves endothelial function in diabetes through activating peroxisome proliferator-activated receptors[J]. Food and Function, 2024, 15(10), 5485-5495.
Authors:  Miao, Lingchao;  Zhou, Yan;  Tan, Dechao;  Zhou, Chunxiu;  Ruan, Cheng Chao; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:5.1/5.6 | Submit date:2024/05/16
Cardiovascular-diseases  Oxidative Stress  Ppar-alpha  Pathway  Hyperglycemia  Management  Expression  
Glycyrrhizic Acid and Its Derivatives: Promising Candidates for the Management of Type 2 Diabetes Mellitus and Its Complications Journal article
Tan, Dechao, Tseng, Hisa Hui Ling, Zhong, Zhangfeng, Wang, Shengpeng, Vong, Chi Teng, Wang, Yitao. Glycyrrhizic Acid and Its Derivatives: Promising Candidates for the Management of Type 2 Diabetes Mellitus and Its Complications[J]. International Journal of Molecular Sciences, 2022, 23(19), 10988.
Authors:  Tan, Dechao;  Tseng, Hisa Hui Ling;  Zhong, Zhangfeng;  Wang, Shengpeng;  Vong, Chi Teng; et al.
Favorite | TC[WOS]:20 TC[Scopus]:23 | Submit date:2022/11/07
Glycyrrhizic Acid  Glycyrrhetinic Acid  Ammonium Glycyrrhizinate  Diammonium Glycyrrhizinate  Type 2 Diabetes Mellitus  Diabetic Complications  Insulin Resistance  Glucose Tolerance  
Holism of Chinese herbal medicine prescriptions for inflammatory bowel disease: A review based on clinical evidence and experimental research Journal article
Siyuan Zhang, Hua Luo, Dechao Tan, Bo Peng, Zhangfeng Zhong, Yitao Wang. Holism of Chinese herbal medicine prescriptions for inflammatory bowel disease: A review based on clinical evidence and experimental research[J]. Phytomedicine, 2022, 102, 154202.
Authors:  Siyuan Zhang;  Hua Luo;  Dechao Tan;  Bo Peng;  Zhangfeng Zhong; et al.
Favorite | TC[WOS]:8 TC[Scopus]:8  IF:6.7/6.2 | Submit date:2022/08/02
Clinical Evidence  Herbal Medicine  Holistic View  Inflammatory Bowel Disease  Omics  
Emerging pharmacotherapy for inflammatory bowel diseases Review article
2022
Authors:  Hua Luo;  Guiqing Cao;  Chun Luo;  Dechao Tan;  Chi Teng Vong ; et al.
Favorite | TC[WOS]:47 TC[Scopus]:51  IF:9.1/9.0 | Submit date:2022/05/04
Emerging Pharmacotherapy  Ibd  Molecular Pathogenesis  Therapeutic Targets  
Salvia miltiorrhiza Bge. (Danshen) for Inflammatory Bowel Disease: Clinical Evidence and Network Pharmacology-Based Strategy for Developing Supplementary Medical Application Journal article
Zhang, Siyuan, Luo, Hua, Sun, Shiyi, Zhang, Yating, Ma, Jiaqi, Lin, Yuting, Yang, Lin, Tan, Dechao, Fu, Chaomei, Zhong, Zhangfeng, Wang, Yitao. Salvia miltiorrhiza Bge. (Danshen) for Inflammatory Bowel Disease: Clinical Evidence and Network Pharmacology-Based Strategy for Developing Supplementary Medical Application[J]. Frontiers in Pharmacology, 2022, 12, 741871.
Authors:  Zhang, Siyuan;  Luo, Hua;  Sun, Shiyi;  Zhang, Yating;  Ma, Jiaqi; et al.
Favorite | TC[WOS]:12 TC[Scopus]:10  IF:4.4/5.0 | Submit date:2022/02/21
Clinical Trial  Danshen  Inflammatory Bowel Disease  Network Pharmacology  Salvia Miltiorrhiza Bge  
The Pharmacological Rationales and Molecular Mechanisms of Ganoderma lucidum Polysaccharides for the Therapeutic Applications of Multiple Diseases Journal article
Luo, Hua, Tan, Dechao, Peng, Bo, Zhang, Siyuan, Vong, Chi Teng, Yang, Zizhao, Wang, Yitao, Lin, Zhibin. The Pharmacological Rationales and Molecular Mechanisms of Ganoderma lucidum Polysaccharides for the Therapeutic Applications of Multiple Diseases[J]. American Journal of Chinese Medicine, 2021, 50(1), 53-90.
Authors:  Luo, Hua;  Tan, Dechao;  Peng, Bo;  Zhang, Siyuan;  Vong, Chi Teng; et al.
Favorite | TC[WOS]:14 TC[Scopus]:13  IF:4.8/5.0 | Submit date:2022/05/17
Ganoderma Lucidum Polysaccharides  Molecular Mechanisms  Network Pharmacology  Pharmacological Rationales  Review  
The key issues and development strategy of Chinese Classical Formulas pharmaceutical preparations Journal article
Hua Luo, Hongguo Chen, Chang Liu, Siyuan Zhang, Chi Teng Vong, Dechao Tan, Yuntao Dai, Yitao Wang, Shilin Chen. The key issues and development strategy of Chinese Classical Formulas pharmaceutical preparations[J]. Chinese Medicine, 2021, 16(1), 70.
Authors:  Hua Luo;  Hongguo Chen;  Chang Liu;  Siyuan Zhang;  Chi Teng Vong; et al.
Favorite | TC[WOS]:14 TC[Scopus]:17  IF:5.3/5.5 | Submit date:2021/12/09
Chinese Classical Formulas  Material Reference  Origin Of The Medicinal Materials  Processing Methods  Dosage Verifcation  Quality Control  Development Strategies  Safety Evaluation  
A recent update on the use of Chinese medicine in the treatment of inflammatory bowel disease Journal article
Yang, Lin, Luo, Hua, Tan, Dechao, Zhang, Siyuan, Zhong, Zhangfeng, Wang, Shengpeng, Vong, Chi Teng, Wang, Yitao. A recent update on the use of Chinese medicine in the treatment of inflammatory bowel disease[J]. Phytomedicine, 2021, 92, 153709.
Authors:  Yang, Lin;  Luo, Hua;  Tan, Dechao;  Zhang, Siyuan;  Zhong, Zhangfeng; et al.
Favorite | TC[WOS]:30 TC[Scopus]:33  IF:6.7/6.2 | Submit date:2021/12/08
Chinese Medicine  Immune Regulation  Inflammatory Bowel Disease  Intestinal Barrier Function  Intestinal Flora